"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The seventh volume of the book features reviews on these topics:
 
· Essential oils and monoterpenes as potential anti-cancer agents
 
· Drug delivery systems and emerging immunotherapeutic strategies for the treatment of glioblastoma
 
· CTDNA in solid tumors
 
· Cholesterol treatments (including Pitavastatin) and their potential in cancer treatment"


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

End User License Agreement (for non-institutional, personal use)

Essential Oils and Monoterpenes as Potential Anti-Cancer Agents

A Glance at Drug Delivery Systems and Emerging Immunotherapeutic Strategies for the Treatment of Glioblastoma

ctDNA in Solid Tumors: Role in Diagnosis, Prognosis and Treatment

Pitavastatin and Cancer: Current and Future Prospects

INTER-CORRELATION BETWEEN CHOLESTEROL TRANSPORTERS AND CELL PROLIFERATION

INTRACELLULAR CHOLESTEROL, CELL CYCLE ACTIVITY AND CELL PROLIFERATION

Cholesterol: A Steer to Cell Cycle Activity and Cell Proliferation

CHOLESTEROL HOMEOSTASIS IN CANCER TUMOUR CELLS

REPROGRAMMED CHOLESTEROL METABOLISM IN CANCER CELLS

IMMUNE CELL SUPPRESSION BY CARCINOGEN AND CARCINOMA

BIPHASIC ROLE OF CHOLESTEROL IN PROMOTING TUMOR CELL PROLIFERATION AND TUMOR DEFENSIVE IMMUNE CELL DEATH

ANTI-CANCER DRUG TARGETS: PREVENTION AGAINST INIMICAL DOUBLE-EDGED REPROGRAMMED CHOLESTEROL HOMEOSTASIS

Cholesterol: A Potential Target for Intervention in Anti-Cancer Therapy

Bentham Science Publishers

"Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters focused on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. This book series should prove to be of interest to all pharmaceutical scientists who are involved in research in drug design and discovery and who wish to keep abreast of rapid and important developments in the field.
 
The ninth volume of this series brings together reviews covering topics related to the treatment of neoplasms, systems biology, respiratory diseases among others.
 
Topics included in this volume are:
 
-Prognostic biomarkers in prostate cancer
-Chemoresistance in cancer cells
-GPCRS in systems and synthetic biology
-Mechanisms of action of ribavirin in different diseases
-Carbon nanotubes and drug targets
-The role of phosphatase I inhibitors in Minkowski spaces
-Phosphodiesterase targeting for treating respiratory diseases
 "


Frontiers in Drug Design & Discovery: Volume 9

Atta-ur-Rahman

Dr. M. lqbal Choudhary 

"Herbal Medicine: Back to the Future compiles expert reviews on the application of herbal medicines (including Ayurveda, Chinese traditional medicines and alternative therapies) to treat different ailments. The book series demonstrates the use of sophisticated methods to understand traditional medicine, while providing readers a glimpse into the future of herbal medicine.
 
This volume presents reviews of traditional Chinese medicine and other nutritional therapies useful for treating cardiovascular diseases, including: 
cardiovascular benefits of the European Olive and bottle gourd
a review of the cardiovascular benefits of Naoxintong
herbal and micronutrient supplements for cardiovascular disease patients
herbal remedies for atherosclerosis
cardio-protective alkaloids
 
This volume is essential reading for all researchers in the field of natural product chemistry and pharmacology. Medical professionals involved in cardiovascular care who seek to improve their knowledge about herbal medicine and alternative therapies will also benefit from the contents of the volume."


Cardiovascular Diseases

Ferid Murad

Ka Bian

"Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.
 
The fifth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:
- Current concepts in management of AD
- The amyloid cascade hypothesis and stem cell-based AD therapy 
- Phytochemicals targeting AD
- Dementia screening in primary clinical care settings
- Updates in dementia / AD clinical research and drug development"


Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 5

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
The sixth volume of this series features reviews that cover the following topics:
-Depression, Insomnia and Atypical Antidepressants
-Combination Therapy of Hypothermia for Hypoxic Encephalopathy in Neonates
-Development of A “Theranostic Nano-Bullet” for Tinnitus
-Dexmedetomidine: From Basic Science to Clinical Application of Brain Protection
-Protein Misfolding, Aggregation, Amyloid Formation in Neurodegenerative Diseases 
 "


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6

"Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD), a disease that causes dementia, or loss of brain function. This disease affects parts of the brain that affect memory, thought, and language. Chapters in each volume focus on drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
 
 
 
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.
 
 
 
The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:
 
- Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
 
- The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs
 
- Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
 
- Use of Antipsychotics in Patients with Alzheimer’s Disease
 
- Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
 
- Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease"



Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

"Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
The third volume of this series features reviews that cover a variety of topics including: 
-Geomic mining and metabolomic techniques for developing antimcrobials
-Probiotic use in complementary antiretroviral therapy
-Anti-HIV pharmaceuticals
-Phytochemicals used for antimicrobial purposes
- Antimicrobial photodynamic therapy (APDT)"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 3

"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics:
 
 
 
- Key data management elements in clinical trials for oncological therapeutics
 
- Prospects for therapeutic targeting of microRNAs in brain tumors
 
- Breast cancer vaccines: current status and future approach
 
- Desmocollin-3 and cancer
 
- MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53
 
- Towards targeted therapy: anticancer agents targeting cell organelle mitochondria
 
- Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults
 
 
 
Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials"


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

"This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The seventh volume of this series features 7 chapters that cover the following topics:
- Gut micriobiota and gastrointestinal cancer
- Dengue virus infections
- Synergistic antibiotic drug interactions
- Molecular modeling of antibacterial drugs
- Nucleic acid aptamers as anti-infective agents
- Fungal multidrug resistance
- The role of hydrogen sulfide in infections 
"


Frontiers in Anti-Infective Drug Discovery: Volume 7

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
 
The tenth volume of the series features chapters covering the following topics:
 
- Challenges in the Management of Hepatoblastoma
 
- The Emerging Role of Monocarboxylate Transporter-1 in Cancer
 
- In-vitro Anti-Proliferative Assays and Techniques Used in Pre-Clinical Anti-Cancer Drug Discovery
 
- Recent Advances in the Development of Mesoporous Anti-Cancer Drug Nanocarriers
 
- Polyphenols and Cancer
 
- Glioblastoma Multiforme
 
- Cutting Edge Targeting Strategies Utilizing Nanotechnology in Breast Cancer Therapy"


Frontiers in Anti-Cancer Drug Discovery: Volume 10

"The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.
Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this series excellent reading both for the novice as well as for expert medicinal chemists and clinicians.
The fifth volume brings together reviews on the following topics:
- Targeted therapy for tumor vasculature
- Anti-angiogenic therapy for breast and prostate cancers (including information updates on clinical trials)
- Microbe-based and other novel antiangiogenesis therapies, including chromene-based agents"


Sepetiniz

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

$ 79.00

description_of_book

Ek Bilgi

Yazarlar Hakkında

Atta-ur-Rahman

Frontiers in Drug Design & Discovery: Volume 9

Cardiovascular Diseases

Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 5

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6

Frontiers in Clinical Drug Research - Alzheimer Disorders Volume 8

Frontiers in Clinical Drug Research - Anti Infectives: Volume 3

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

Frontiers in Anti-Infective Drug Discovery: Volume 7

Frontiers in Anti-Cancer Drug Discovery: Volume 10

Anti-Angiogenesis Drug Discovery and Development: Volume 5

Atta-ur-Rahman